Beaird Harris Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
SLAM
Beaird Harris Wealth Management's BMY Position: Q2 2026 in Review
Beaird Harris Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.25% in Q2 2026, buying an estimated $230 and bringing the position to 1,607 shares worth $92.6K. The position accounts for 0.01% of the portfolio, ranked #215.
Beaird Harris Wealth Management first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $103K in Q1 2025. 1,031 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Beaird Harris Wealth Management held 1,607 shares of Bristol-Myers Squibb worth $92.6K as of Q2 2026.
- Beaird Harris Wealth Management bought 4 Bristol-Myers Squibb shares in Q2 2026, an estimated $230.
- Bristol-Myers Squibb made up 0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #215 holding.
- Beaird Harris Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Beaird Harris Wealth Management's Bristol-Myers Squibb position peaked at $103K in Q1 2025.
- 1,031 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.